Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-25FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Fluticasone Propionate from Hikma Pharmaceuticals USA Inc., under the ANDA program.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Prednisolone Pharmacokinetics in Severe Asthma [Phase 4]
Phase 4 clinical trial examining pharmacokinetics of prednisolone in severe asthma completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma [Phase 4]
Phase 4 clinical trial evaluating monodisperse fluticasone propionate in asthma has completed with posted results.
-
FDA approval · 2019-11-15FDA Approved: PREDNISONE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approves ANI Pharmaceuticals' original (generic) application for prednisone, enabling a generic prednisone product to be marketed.
-
FDA approval · 2019-11-08FDA Approved: PROVOCHOLINE — Supplemental Application (Methapharm Inc.)
The FDA approves a supplemental application for ProvoCholine (methacholine chloride inhalation solution) submitted by Methapharm Inc., allow…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Montelukast submitted by BluePoint Laboratories. The action pertains to an additional indication…
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for montelukast sodium.
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, enabling the generic montelukast product (ANDA 20…
-
FDA approval · 2019-11-08FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application for Montelukast Sodium, updating regulatory status for the product.
-
FDA approval · 2019-11-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for montelukast sodium under ANDA202717, resulting in an updated approved product.…
-
FDA approval · 2019-11-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental ANDA for montelukast sodium from Rising Pharma Holdings, enabling the marketing of a generic montelukast sodium …
-
FDA approval · 2019-11-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., enabling a generic product entry. This dec…
-
CLINICAL_TRIALS research · 2019-11-04Clinical Trial Update: Environmental Control as Add-on Therapy in Childhood Asthma [Phase 2]
Phase 2 clinical trial evaluating environmental control as add-on therapy for childhood asthma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Airway Smooth Muscle and Asthma Severity
Clinical trial update for an asthma study completed by Imperial College London with results posted in 2019.
-
CLINICAL_TRIALS research · 2019-10-31Clinical Trial Update: Exacerbations in Severe Asthma Patients: Mechanisms and Biomarkers [NA]
Clinical trial update investigating mechanisms and biomarkers related to exacerbations in severe asthma patients; results completed with pos…
-
FDA approval · 2019-10-29FDA Approved: BUDESONIDE — Supplemental Application (Rite Aid Corporation)
FDA approved a supplemental application for Budesonide by Rite Aid Corporation, expanding or modifying the approval of this generic product.
-
CLINICAL_TRIALS research · 2019-10-29Clinical Trial Update: Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN) [NA]
Clinical trial evaluating interventions to teach inhaler technique in asthma and COPD; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Inspiratory Muscle Training and Asthma [NA]
A completed clinical trial investigating inspiratory muscle training for asthma; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: AZD1419 Ph2a Study [Phase 2]
Phase 2a clinical trial update for AZD1419 in asthma; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma [Phase 1]
Phase 1 study evaluating pharmacokinetics, safety, and tolerability of single doses of VR647 inhalation suspension in children with wheezing…
-
CLINICAL_TRIALS research · 2019-10-21Clinical Trial Update: Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma
A completed clinical trial investigating exhaled hydrogen sulfide as a biomarker for asthma.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis [Phase 4]
Phase 4 trial update on the steroid-sparing effect of a nasal corticosteroid in asthma and allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Health Effects of Diesel Exhaust in Asthmatic Patients: A Real-world Study in a London Street [NA]
A completed real-world study assessing health effects of diesel exhaust in asthmatic patients, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma [EARLY_Phase 1]
Early Phase 1 trial evaluating an in vitro effect of a novel drug on airway epithelial cells from participants with severe asthma has comple…
-
CLINICAL_TRIALS trial_result · 2019-10-09Clinical Trial Update: The Health Access and Recovery Peer Program [NA]
Clinical trial update for the Health Access and Recovery Peer Program; study completed with posted results.